Keyphrases
Caveolin-1 (Cav-1)
100%
Ovarian Carcinoma
100%
Advanced Stage
100%
Clinicopathologic Study
100%
Disease Outcome
37%
Short-term Survivors
37%
Tumor
25%
Immunoreactivity
25%
Long-term Survivors
25%
Carcinoma
25%
Non-neoplastic
25%
Protein Expression
12%
Expression Level
12%
Statistical Significance
12%
In Vivo Evidence
12%
Signal Transduction
12%
Cell Membrane
12%
Immunohistochemistry
12%
Reduced Expression
12%
Tumor Suppressor Gene
12%
In Vitro Study
12%
Metastasis
12%
Epidermal Growth Factor Receptor
12%
Tyrosine Kinase
12%
Primary Tumor
12%
Overall Survival
12%
Fallopian Tube
12%
Stage III-IV
12%
Epithelium
12%
Disease-free Survival
12%
Caveolae
12%
C-erbB-2
12%
Human Malignancies
12%
Metastatic Lesions
12%
Patient Cohort
12%
Membrane Expression
12%
Non-neoplastic Lesion
12%
FIGO Stage
12%
Primary Ovarian Carcinoma
12%
Medicine and Dentistry
Krukenberg Tumor
100%
Caveolin 1
100%
Disease
37%
Neoplasm
25%
Carcinoma
25%
Immunoreactivity
25%
In Vitro
12%
Cell Membrane
12%
Protein Expression
12%
Tumor Suppressor Gene
12%
Epidermal Growth Factor Receptor
12%
Metastatic Carcinoma
12%
Immunohistochemistry
12%
Signal Transduction
12%
Cancer
12%
Protein Tyrosine Kinase
12%
Primary Tumor
12%
Overall Survival
12%
Fallopian Tube
12%
Disease Free Survival
12%
Caveolae
12%
Pharmacology, Toxicology and Pharmaceutical Science
Caveolin 1
100%
Ovary Carcinoma
100%
Disease
37%
Neoplasm
25%
Carcinoma
25%
Protein Tyrosine Kinase
12%
Primary Tumor
12%
Overall Survival
12%
Disease Free Survival
12%
Epidermal Growth Factor Receptor
12%
Tumor Suppressor Protein
12%